APD prescription: achieving the adequacy goals

Area of Science:

• Nephrology
• Biomedical Engineering

Background:

• Automated peritoneal dialysis (APD) has seen significant technological advancements.
• The minimal dose for peritoneal dialysis (PD) remains incompletely defined.
• Evaluating dialytic efficiency using specific indexes and targets is crucial for appropriate APD use.

Purpose of the Study:

• To explore the definition of minimal peritoneal dialysis dose.
• To discuss the evaluation of dialytic efficiency and targets in APD.
• To highlight factors for achieving optimal dialytic dose and enhancing APD utilization.

Main Methods:

• Review of current technological developments in APD.
• Analysis of dialytic indexes and adequacy targets.
• Consideration of mass transfer, intraperitoneal volumes, and peritoneal membrane characteristics.
• Evaluation of biocompatible treatments, glucose profiling, and alternative PD fluids.
• Assessment of new high-flow techniques like continuous flow PD.

Main Results:

• Technological improvements have enhanced APD.
• Optimizing mass transfer, tailoring treatments, and using biocompatible fluids are key to optimal dosing.
• New high-flow techniques improve urea and creatinine clearance and ultrafiltration.
• Continuous flow PD shows promise for increased APD modality utilization.

Conclusions:

• Achieving optimal dialytic dose in APD requires a multifaceted approach.
• Personalized treatment strategies and biocompatible fluids are essential.
• Advanced techniques like continuous flow PD offer improved efficiency and greater potential for APD adoption.